(Q36072188)

12 August 2017

title

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study (English)

1 reference

12 August 2017

0 references

1 reference

Graham A Colditz

5

0 references

Rulla M Tamimi

series ordinal

2

object named as

Rulla M Tamimi

1 reference

12 August 2017

6

Stuart J Schnitt

1 reference

12 August 2017

3

Heather J Baer

1 reference

12 August 2017

1

Laura C Collins

1 reference

12 August 2017

James L Connolly

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

103

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

1778-1784

1 reference

Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

The transition from hyperplasia to invasive carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Ductal carcinoma in situ in breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Treatment selection in ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

The Diagnosis and Treatment of Ductal Carcinoma In Situ of the Breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Gene expression profiles of human breast cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Ductal Carcinoma in Situ of the Breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

The certainties and the uncertainties of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

The clinical significance of pre-invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Duct carcinoma in situ. Pathology and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20979

7 January 2021

Identifiers

DOI

10.1002/CNCR.20979

1 reference

12 August 2017

1 reference